Form 4 for EW Edwards Lifesciences
Accepted 2026-08-28 16:32:52 ET · period of report 2026-08-28 · accession 0001225208-26-007377 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-28 16:32 | 2026-08-28 | EW | Bruls Annette | CVP, EMEACLA | S - Sale | $89.98 | -2,644 | 18.0K | -13% | -$237.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-28 | S | D | 2,644 | $89.98 | 17,984 | D | — | — |